Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1[MYK-461][1] Mavacamten (MYK-461)[1] Mavacamten 💬 [1] MYH7 💬 [9] Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Motor proteins, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬[1] 58 💬
2MavacamtenProduct Code: MYK-461Pharmaceutical Form: Capsule, hardINN or Proposed INN: NACAS Number: NACurrent Sponsor code: MYK-461Other descriptive name: MAVACAMTENConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 15-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral useProduct Name: MavacamtenProduct Code: MYK-461Pharmaceutical Form: Capsule, hardINN or Proposed INN: NACAS Number: NACurrent Sponsor code: MYK-461Other descriptive name: MAVACAMTENConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral useProduct Name: MavacamtenProduct Code: MYK-461Pharmaceutical Form: Capsule, hardINN or Proposed INN: NACAS Number: NACurrent Sponsor code: MYK-461Other descriptive name: MAVACAMTENConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral useProduct Name: MavacamtenProduct Code: MYK-461Pharmaceutical Form: Capsule, hardINN or Proposed INN: NACAS Number: NACurrent Sponsor code: MYK-461Other descriptive name: MAVACAMTENConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 2.5-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral useProduct Name: MavacamtenProduct Code: MYK-461Pharmaceutical Form: Capsule, hardINN or Proposed INN: NACAS Number: NACurrent Sponsor code: MYK-461Other descriptive name: MAVACAMTENConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 1-Pharmaceutical form of the pla----[1] 58 💬
3MYK-461[1] Mavacamten (MYK-461)[1] Mavacamten 💬 [1] MYH7 💬 [9] Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Motor proteins, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬[1] 58 💬